Incidence and risk factors for chronic kidney disease after hematopoietic stem cell transplantation

Alina Tanase1, Andreea Andronesi2,3, Bogdan Sorohan2,3

  • 1Bone Marrow Transplant Department, Fundeni Clinical Institute, Bucharest, Romania.

Renal Failure
|August 4, 2025
PubMed

Insights

Chronic kidney disease (CKD) after hematopoietic stem cell transplantation (HSCT) is a growing concern. Longer disease duration and older age are key risk factors for developing CKD post-transplant.

Area of Science:

  • Nephrology
  • Hematology
  • Transplantation Medicine

Background:

  • Chronic kidney disease (CKD) is an increasing complication following hematopoietic stem cell transplantation (HSCT).
  • Limited research exists on CKD incidence and risk factors in HSCT survivors.
  • Identifying risk factors is crucial for managing this comorbidity.

Purpose of the Study:

  • To prospectively evaluate the incidence of CKD in patients undergoing allogeneic HSCT.
  • To identify risk factors associated with the development and persistence of low glomerular filtration rate (GFR).

Main Methods:

  • Prospective assessment of 197 patients who received allogeneic HSCT.
  • Monitoring of glomerular filtration rate (GFR) and identification of persistent low GFR.
  • Cox proportional hazard analysis to determine risk factors for CKD.

Main Results:

  • CKD incidence was 11.7% with a median onset of 6 months post-HSCT.
  • Older age and longer duration of hematologic disease were significant predictors of CKD.
  • Acute lymphoblastic leukemia was associated with a reduced risk of developing CKD.

Conclusions:

  • CKD is an important comorbidity in improving HSCT survival rates.
  • Hematologic disease length and baseline estimated GFR are independent risk factors for renal dysfunction post-HSCT.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
93
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
68
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
82
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
76
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94